Tailor an Options Trading Strategy to Fit Your Needs

From RJO Futures | Ad

This guide will help you identify and execute an options trading strategy that fits your specific needs and risk profile.

Take your trading to the next level with the Options Strategy Guide.

Download your FREE Options Strategy Guide Today.

ALNY Insider Trading (Alnylam Pharmaceuticals)

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 1.40%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $29,394,580.17

Alnylam Pharmaceuticals Insider Trading History Chart

Alnylam Pharmaceuticals Share Price & Price History

^$148.25

▲ +2.4 (1.65%)

As of 07/1/2022 04:59 PM ET

Days: 30 | 90 | 365

Being A Successful Trader Just Got Easier…

From Tradewins | Ad

From 10x Trading Champion Chuck Hughes comes the e-book helping thousands to survive the bear market, “Options trading Made Easy”!

Already full of tools and strategies for success, each copy now comes with a daily Trade of the Day, straight from Chuck to you!

Download your copy now!

>>>

Alnylam Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/1/2022	Steven M. Paul	Director	Sell	15,000	$170.69	$2,560,350.00	1,000
12/23/2021	Akshay Vaishnaw	Insider	Sell	2,879	$190.93	$549,687.47
11/12/2021	John Maraganore	CEO	Sell	33,978	$171.52	$5,827,906.56
8/13/2021	John Maraganore	CEO	Sell	33,979	$199.78	$6,788,324.62	248,744
8/6/2021	Yvonne Greenstreet	COO	Sell	53,064	$199.00	$10,559,736.00
8/5/2021	Laurie Keating	EVP	Sell	10,000	$188.95	$1,889,500.00	13,008
7/12/2021	Laurie Keating	EVP	Sell	6,812	$178.96	$1,219,075.52	6,944
6/18/2021	Akshay Vaishnaw	Insider	Sell	14,708	$175.00	$2,573,900.00	24,953
6/9/2021	Laurie Keating	EVP	Sell	1,734	$154.00	$267,036.00	5,132
5/13/2021	John Maraganore	CEO	Sell	33,979	$130.78	$4,443,773.62	248,744
4/21/2021	Akshay Vaishnaw	Insider	Sell	2,732	$136.95	$374,147.40	22,908
4/19/2021	Akshay Vaishnaw	Insider	Sell	3,706	$137.67	$510,205.02	22,908
1/12/2021	Laurie Keating	EVP	Sell	14,941	$160.20	$2,393,548.20	2,234
1/12/2021	Yvonne Greenstreet	COO	Sell	3,125	$161.00	$503,125.00	7,945
12/18/2020	Steven M. Paul	Director	Sell	15,000	$140.00	$2,100,000.00	16,000
11/25/2020	Phillip A. Sharp	Director	Sell	30,000	$124.89	$3,746,700.00	265,633
9/29/2020	Akshay Vaishnaw	Insider	Sell	971	$140.00	$135,940.00	15,090
9/9/2020	Barry E Greene	President	Sell	44,530	$123.23	$5,487,431.90	65,412
8/20/2020	John Maraganore	CEO	Sell	34,765	$136.13	$4,732,559.45
7/13/2020	Laurie Keating	EVP	Sell	47,250	$160.67	$7,591,657.50	16,433
7/9/2020	Yvonne Greenstreet	COO	Sell	11,236	$161.00	$1,808,996.00	15,759
7/7/2020	Barry E Greene	President	Sell	22,265	$159.99	$3,562,177.35	84,501
5/20/2020	John Maraganore	CEO	Sell	34,765	$143.22	$4,979,043.30	232,354
5/6/2020	Barry E Greene	President	Sell	22,265	$149.99	$3,339,527.35	84,501
5/5/2020	Yvonne Greenstreet	COO	Sell	7,811	$140.00	$1,093,540.00	11,070
4/20/2020	Akshay Vaishnaw	Insider	Sell	21,971	$140.00	$3,075,940.00	35,119
4/20/2020	Laurie Keating	EVP	Sell	10,000	$139.00	$1,390,000.00	24,492
2/20/2020	John Maraganore	CEO	Sell	34,765	$131.85	$4,583,765.25	224,758
2/10/2020	Steven M. Paul	Director	Sell	30,000	$130.00	$3,900,000.00	31,000
2/10/2020	Yvonne Greenstreet	COO	Sell	9,892	$130.00	$1,285,960.00	12,458
2/7/2020	Akshay Vaishnaw	Insider	Sell	23,708	$125.00	$2,963,500.00	30,923
2/7/2020	Yvonne Greenstreet	COO	Sell	6,250	$123.90	$774,375.00	12,458
1/29/2020	Laurie Keating	EVP	Sell	6,337	$119.00	$754,103.00	14,932
1/27/2020	Laurie Keating	EVP	Sell	41,037	$117.70	$4,830,054.90	24,632
11/20/2019	Marsha Fanucci	Director	Sell	75,000	$100.00	$7,500,000.00	30,000
11/20/2019	Yvonne Greenstreet	COO	Sell	8,404	$105.00	$882,420.00	4,070
11/18/2019	Phillip A. Sharp	Director	Sell	15,000	$91.71	$1,375,650.00	250,633
10/22/2019	Barry E Greene	President	Sell	58,913	$89.99	$5,301,580.87	111,851
10/14/2019	John Maraganore	CEO	Sell	49,456	$79.45	$3,929,279.20	239,449

Trading With A Small Account?

From Tradewins | Ad

If you’ve been told it’s not doable, you’ve been lied to! Hi, I’m pro-trader Chuck Hughes and I grew my once tiny investment into an empire!

If you want to do the same–or simply want to feel more secure in your finances–”Options Trading Made Easy” is the guide you need.

Get a copy here!

>>>

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.39% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Alnylam Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
6/30/2022	Amalgamated Bank	13,355	$2.18M	0.0%	+27.5%	0.011%
6/7/2022	Teachers Retirement System of The State of Kentucky	66,123	$10.80M	0.1%	+13.8%	0.055%
6/2/2022	Mirae Asset Global Investments Co. Ltd.	65,572	$10.71M	0.0%	-12.8%	0.054%
5/23/2022	Neuberger Berman Group LLC	6,285	$1.03M	0.0%	+69.8%	0.005%
5/20/2022	International Biotechnology Trust PLC	38,000	$21.71M	4.9%	-70.3%	0.031%
5/20/2022	The Manufacturers Life Insurance Company	1,997,762	$326.98M	0.3%	+17.3%	1.654%
5/20/2022	Toroso Investments LLC	2,403	$0.39M	0.0%	+10.2%	0.002%
5/19/2022	Capital World Investors	5,999,674	$979.69M	0.2%	+1,781.1%	4.966%
5/19/2022	Capital International Sarl	13,315	$2.17M	0.1%	N/A	0.011%
5/19/2022	Capital International Ltd. CA	21,839	$3.57M	0.2%	N/A	0.018%
5/19/2022	Capital Group International Inc. CA	19,390	$3.17M	0.0%	N/A	0.016%
5/18/2022	BNP Paribas Arbitrage SA	66,700	$10.89M	0.0%	+1.0%	0.055%
5/17/2022	Wealthfront Advisers LLC	12,845	$2.10M	0.0%	+873.8%	0.011%
5/17/2022	Virtu Financial LLC	3,862	$0.63M	0.0%	-53.5%	0.003%
5/17/2022	Advisors Asset Management Inc.	3,936	$0.64M	0.0%	+8.0%	0.003%
5/17/2022	Meiji Yasuda Asset Management Co Ltd.	1,250	$0.20M	0.0%	-10.7%	0.001%
5/17/2022	Beacon Pointe Advisors LLC	1,740	$0.28M	0.0%	+29.4%	0.001%
5/17/2022	Polar Capital Holdings Plc	229,833	$37.53M	0.2%	-57.1%	0.190%
5/17/2022	Prosight Management LP	22,704	$3.71M	2.4%	-28.8%	0.019%
5/17/2022	Quantbot Technologies LP	3,806	$0.62M	0.1%	N/A	0.003%
5/17/2022	Royal Bank of Canada	22,595	$3.69M	0.0%	-19.9%	0.019%
5/17/2022	RTW Investments LP	1,683,362	$274.88M	5.7%	-14.8%	1.393%
5/17/2022	Eaton Vance Management	306,228	$50.01M	0.1%	+606.7%	0.253%
5/17/2022	Endurant Capital Management LP	10,379	$1.70M	0.4%	N/A	0.009%
5/17/2022	Ensign Peak Advisors Inc	36,430	$5.95M	0.0%	-10.6%	0.030%
5/17/2022	Farallon Capital Management LLC	1,023,873	$167.19M	0.9%	-14.0%	0.848%
5/17/2022	Gilder Gagnon Howe & Co. LLC	791,224	$129.20M	1.2%	-5.8%	0.655%
5/17/2022	Guggenheim Capital LLC	25,744	$4.20M	0.0%	-2.1%	0.021%
5/17/2022	1832 Asset Management L.P.	545	$88K	0.0%	N/A	0.000%
5/16/2022	California State Teachers Retirement System	199,213	$32.53M	0.0%	-5.0%	0.165%
5/16/2022	Goldman Sachs Group Inc.	681,553	$111.29M	0.0%	-0.7%	0.564%
5/16/2022	Captrust Financial Advisors	1,232	$0.20M	0.0%	+36.4%	0.001%
5/16/2022	Allstate Corp	8,077	$1.32M	0.0%	-25.6%	0.007%
5/16/2022	Wellington Management Group LLP	7,034,487	$1.15B	0.2%	+2.8%	5.823%
5/16/2022	Deep Track Capital LP	463,663	$75.71M	4.9%	-4,062.9%	0.384%
5/16/2022	State Street Corp	2,909,490	$475.09M	0.0%	+2.1%	2.408%
5/16/2022	Echo Street Capital Management LLC	2,101	$0.34M	0.0%	-46.6%	0.002%
5/16/2022	Eversept Partners LP	52,871	$8.63M	0.7%	-24.7%	0.044%
5/16/2022	Vident Investment Advisory LLC	12,161	$1.98M	0.1%	+73.1%	0.010%
5/16/2022	Invesco Ltd.	968,755	$158.19M	0.0%	+8.8%	0.802%
5/16/2022	UBS Group AG	27,976	$4.57M	0.0%	-68.7%	0.023%
5/16/2022	Hsbc Holdings PLC	47,827	$7.82M	0.0%	+15.7%	0.040%
5/13/2022	Rhenman & Partners Asset Management AB	130,000	$21.23M	2.1%	-25.7%	0.108%
5/13/2022	Bellevue Group AG	1,229,563	$200.78M	2.3%	-7.9%	1.018%
5/13/2022	Northern Trust Corp	763,340	$124.65M	0.0%	-0.8%	0.632%
5/13/2022	Charles Schwab Investment Management Inc.	372,623	$60.85M	0.0%	+2.7%	0.308%
5/13/2022	Edgestream Partners L.P.	4,002	$0.65M	0.1%	-81.8%	0.003%
5/13/2022	Lazard Asset Management LLC	1,065	$0.17M	0.0%	+47.3%	0.001%
5/13/2022	Utah Retirement Systems	21,372	$3.49M	0.0%	-0.5%	0.018%
5/13/2022	Rosenblum Silverman Sutton S F Inc CA	41,761	$6.82M	1.7%	-1.4%	0.035%
5/13/2022	DCF Advisers LLC	19,000	$3.10M	1.4%	+5.6%	0.016%
5/13/2022	First Trust Advisors LP	402,652	$65.75M	0.1%	-20.6%	0.333%
5/13/2022	XTX Topco Ltd	1,497	$0.24M	0.1%	N/A	0.001%
5/13/2022	Royal London Asset Management Ltd.	41,560	$6.79M	0.0%	+3.1%	0.034%
5/13/2022	USS Investment Management Ltd	79,962	$13.06M	0.1%	+5.6%	0.066%
5/13/2022	Pearl River Capital LLC	2,875	$0.47M	0.1%	-41.3%	0.002%
5/13/2022	Parkman Healthcare Partners LLC	54,008	$8.82M	2.6%	-6.4%	0.045%
5/13/2022	Tekla Capital Management LLC	158,606	$25.90M	0.9%	-16.4%	0.131%
5/13/2022	Mackenzie Financial Corp	19,376	$3.16M	0.0%	+11.3%	0.016%
5/13/2022	Loomis Sayles & Co. L P	868,748	$141.86M	0.2%	-12.8%	0.719%
5/13/2022	Baird Financial Group Inc.	1,379	$0.23M	0.0%	+15.5%	0.001%
5/13/2022	Candriam Luxembourg S.C.A.	303,653	$49.58M	0.3%	+26.2%	0.251%
5/13/2022	Vanguard Group Inc.	10,829,144	$1.77B	0.0%	+1.2%	8.964%
5/13/2022	National Pension Service	180,898	$29.54M	0.1%	+2.9%	0.150%
5/13/2022	Prudential PLC	1,781	$0.29M	0.0%	N/A	0.001%
5/13/2022	Allianz Asset Management GmbH	44,928	$7.34M	0.0%	-12.0%	0.037%
5/13/2022	Canada Pension Plan Investment Board	1,013	$0.17M	0.0%	-98.2%	0.001%
5/13/2022	Aviva PLC	73,040	$11.93M	0.1%	+91.1%	0.060%
5/13/2022	Sei Investments Co.	28,442	$4.59M	0.0%	+11.8%	0.024%
5/13/2022	Vontobel Holding Ltd.	6,446	$1.07M	0.0%	-10.9%	0.005%
5/13/2022	Dimensional Fund Advisors LP	181,271	$29.60M	0.0%	+1.2%	0.150%
5/12/2022	BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp	18,462	$3.02M	0.0%	-11.9%	0.015%
5/12/2022	Westwood Holdings Group Inc.	16,380	$2.67M	0.0%	-9.3%	0.014%
5/12/2022	Great West Life Assurance Co. Can	62,369	$10.79M	0.0%	+21.2%	0.052%
5/12/2022	APG Asset Management N.V.	7,097	$1.04M	0.0%	-21.1%	0.006%
5/12/2022	BlackRock Inc.	7,608,954	$1.24B	0.0%	-0.8%	6.298%
5/12/2022	Rhumbline Advisers	115,877	$18.92M	0.0%	-3.3%	0.096%
5/12/2022	Panagora Asset Management Inc.	6,565	$1.07M	0.0%	+96.4%	0.005%
5/12/2022	MetLife Investment Management LLC	7,763	$1.27M	0.0%	N/A	0.006%
5/12/2022	VELA Investment Management LLC	2,975	$0.49M	0.3%	+22.4%	0.002%
5/12/2022	Aureus Asset Management LLC	2,563	$0.42M	0.0%	N/A	0.002%
5/12/2022	D.A. Davidson & CO.	3,981	$0.65M	0.0%	-5.9%	0.003%
5/12/2022	Bank of Montreal Can	73,751	$12.43M	0.0%	+86.8%	0.061%
5/12/2022	Natixis Advisors L.P.	10,359	$1.69M	0.0%	-17.3%	0.009%
5/12/2022	E Fund Management Co. Ltd.	1,732	$0.28M	0.0%	N/A	0.001%
5/12/2022	Eagle Asset Management Inc.	255,937	$41.79M	0.2%	+0.2%	0.212%
5/12/2022	AlphaCrest Capital Management LLC	3,763	$0.61M	0.0%	+34.9%	0.003%
5/12/2022	Eagle Health Investments LP	131,244	$21.43M	5.3%	+15.4%	0.109%
5/12/2022	Harvest Fund Management Co. Ltd	342	$55K	0.0%	-60.9%	0.000%
5/12/2022	Mitsubishi UFJ Trust & Banking Corp	468,452	$76.49M	0.2%	-0.5%	0.388%
5/12/2022	Private Advisor Group LLC	3,472	$0.57M	0.0%	-9.2%	0.003%
5/12/2022	Cetera Advisor Networks LLC	4,299	$0.70M	0.0%	+44.0%	0.004%
5/12/2022	Oppenheimer & Co. Inc.	5,012	$0.82M	0.0%	+76.3%	0.004%
5/12/2022	HighTower Advisors LLC	134,689	$21.99M	0.0%	+3.9%	0.111%
5/12/2022	Blueshift Asset Management LLC	5,506	$0.90M	0.1%	-3.4%	0.005%
5/11/2022	US Bancorp DE	10,278	$1.68M	0.0%	+7.1%	0.009%
5/11/2022	American Century Companies Inc.	1,131,844	$184.82M	0.1%	+12.9%	0.937%
5/11/2022	Seven Eight Capital LP	1,764	$0.29M	0.0%	N/A	0.001%
5/11/2022	Astrantus Ltd	1,900	$0.31M	0.5%	-44.4%	0.002%
5/11/2022	Bank of New York Mellon Corp	638,868	$104.32M	0.0%	+6.1%	0.529%

Data available starting January 2016

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria (AHP); and OXLUMO (lumasiran) for the treatment of primary hyperoxaluria type 1 (PH1). In addition, the company is developing givosiran for the treatment of adolescent patients with AHP; patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; ALN-AAT02 for the treatment of AAT deficiency-associated liver disease; ALN-HBV02 to treat chronic HBV infection; Zilebesiran to treat hypertension; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia and rare bleeding disorders, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1 and recurrent renal stones, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Sanofi Genzyme to discover, develop, and commercialize RNAi therapeutics. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $148.25

$144.67

$148.40

50 Day Range

MA: $135.19

$120.42

$162.07

52 Week Range

Now: $148.25

$117.58

$212.00

Volume

29,478 shs

Average Volume

852,649 shs

Market Capitalization

$17.91 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.8

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?: Alnylam Pharmaceuticals' top insider investors include:
Phillip A Sharp (Director)
John Maraganore (CEO)
Barry E Greene (President)
Akshay Vaishnaw (Insider)
Laurie Keating (EVP)
Steven M Paul (Director)
Yvonne Greenstreet (COO)
Jeffrey W Dunn (CEO)
Learn More about top insider investors at Alnylam Pharmaceuticals.